Profile

Christopher Silber worked as a Principal at Hospira, Inc. He then served as the Vice President-Clinical Affairs at OVATION Pharmaceuticals, Inc. from 2008 to 2010.
Later, he held the position of Senior Vice President-Clinical Development at SAGE Therapeutics, Inc. from 2017 to 2020.
Dr. Silber also worked as the Chief Medical Officer at Nocion Therapeutics, Inc. Currently, he is the Chief Medical Officer at Vigil Neuroscience, Inc. Dr. Silber completed his undergraduate studies at Tufts University and obtained a doctorate degree from Jacobs School of Medicine & Biomedical Sciences.

Former positions of Christopher Silber

CompaniesPositionEnd
VIGIL NEUROSCIENCE, INC. Chief Tech/Sci/R&D Officer 2024-03-19
SAGE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer 2010-03-28
Chief Tech/Sci/R&D Officer -
HOSPIRA, INC. Corporate Officer/Principal -
See the detail of Christopher Silber's experience

Training of Christopher Silber

Tufts University Undergraduate Degree
Jacobs School of Medicine & Biomedical Sciences Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Christopher Silber's experience

Connections

25

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
SAGE THERAPEUTICS, INC.

Health Technology

VIGIL NEUROSCIENCE, INC.

Health Technology

Private companies3

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Christopher Silber
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW